Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin

Author(s):
Huis-Tanja, L.H. van; Kweekel, D.M.; Lu, X.B.; Franken, K.; Koopman, M.; Gelderblom, H.; Antonini, N.F.; Punt, C.J.A.; Guchelaar, H.J. (0000-0002-7085-1383); Straaten, T. van der
Published
2014
Publication type
Article / Letter to editor
ERCC1Colorectal cancerPharmacogenomicsOxaliplatinDNA repair
Date issued
2014-01-31
Language
English
Is part of
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis (2014), Vol. 759, p. 37-44
hdl
1887/107317
doi
10.1016/j.mrfmmm.2013.11.001